These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21839323)

  • 21. Generalized benign cutaneous reaction to cytarabine.
    Ruben BS; Yu WY; Liu F; Truong SV; Wang KC; Fox LP
    J Am Acad Dermatol; 2015 Nov; 73(5):821-8. PubMed ID: 26321388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case of purpuric drug eruption probably induced by panitumumab.
    Senda N; Miyagaki T; Oka T; Nonogaki A; Yoshizaki A; Shibata S; Sato S
    J Dermatol; 2019 Jun; 46(6):e221-e222. PubMed ID: 30537161
    [No Abstract]   [Full Text] [Related]  

  • 23. Late onset perforating folliculitis induced by lenalidomide: a case report.
    Kuiper EM; Kardaun SH
    Br J Dermatol; 2015 Aug; 173(2):618-20. PubMed ID: 25641160
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of isotretinoin-induced purpura annularis telangiectodes of Majocchi and review of substance-induced pigmented purpuric dermatosis.
    Kaplan R; Meehan SA; Leger M
    JAMA Dermatol; 2014 Feb; 150(2):182-4. PubMed ID: 24284887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erlotinib induced target-like purpura.
    Rungtrakulchai R; Rerknimitr P
    Dermatol Online J; 2014 Feb; 20(2):. PubMed ID: 24612572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Eruption of purpura compatible with vasculitis and torasemide].
    Sanfélix Genovés J; Benlloch Nieto H; Verdú Tárraga R; Costa Alcaraz AM
    Aten Primaria; 1998 Mar; 21(4):252-3. PubMed ID: 9607256
    [No Abstract]   [Full Text] [Related]  

  • 27. Purpuric drug eruption with leukocytoclastic vasculitis due to gefitinib.
    Uchimiya H; Higashi Y; Kawai K; Kanekura T
    J Dermatol; 2010 Jun; 37(6):562-4. PubMed ID: 20536674
    [No Abstract]   [Full Text] [Related]  

  • 28. Idiopathic pigmented purpuric eruption with palmar-plantar involvement.
    Geary RC; Marks VJ
    Cutis; 1987 Aug; 40(2):109-13. PubMed ID: 2957173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen and purpuric vasculitis.
    Drago F; Arditi M; Rebora A
    Ann Intern Med; 1990 Jun; 112(12):965-6. PubMed ID: 2140253
    [No Abstract]   [Full Text] [Related]  

  • 30. Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.
    Tapan U; Seldin DC; Finn KT; Fennessey S; Shelton A; Zeldis JB; Sanchorawala V
    Blood; 2010 Dec; 116(23):5071-2. PubMed ID: 21127185
    [No Abstract]   [Full Text] [Related]  

  • 31. Kidney dysfunction during lenalidomide treatment for AL amyloidosis.
    Specter R; Sanchorawala V; Seldin DC; Shelton A; Fennessey S; Finn KT; Zeldis JB; Dember LM
    Nephrol Dial Transplant; 2011 Mar; 26(3):881-6. PubMed ID: 20693160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous reaction to vasopressin.
    Lemlich G; Di Grandi S; Szaniawski WK
    Cutis; 1996 May; 57(5):330-2. PubMed ID: 8726714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Suspected itchy rash secondary to lenalidomide].
    Escudero-Vilaplana V; Osorio Prendes S; Sanjurjo Sáez M
    Farm Hosp; 2014 Nov; 38(6):495-6. PubMed ID: 25542665
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and histopathologic correlation of an eruption secondary to Taxotere.
    Beer K; Oakley H
    J Drugs Dermatol; 2010 Dec; 9(12):1534-5. PubMed ID: 21120264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prednisolone purpura.
    Singhvi GR; Chordiya AV
    J Assoc Physicians India; 1989 Aug; 37(8):541-2. PubMed ID: 2533597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocytoclastic vasculitis following lenalidomide during the treatment of follicular lymphoma.
    Loree JM; Cai E; Sheffield BS; Dutz JP; Villa D; Shepherd LE; Connors JM; Sehn LH; Savage KJ
    Leuk Lymphoma; 2017 Mar; 58(3):711-714. PubMed ID: 27557805
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings.
    Karadag AS; Ozlu E; Akdeniz N; Uzuncakmak TK; Turkoglu Z; Ozkanli S; Zemheri E
    Cutan Ocul Toxicol; 2016; 35(2):157-9. PubMed ID: 26339719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purpuric contact dermatitis to benzoyl peroxide.
    van Joost T; van Ulsen J; Vuzevski VD; Naafs B; Tank B
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 2):359-61. PubMed ID: 2137465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide.
    Palladini G; Russo P; Foli A; Milani P; Lavatelli F; Obici L; Nuvolone M; Brugnatelli S; Invernizzi R; Merlini G
    Ann Hematol; 2012 Jan; 91(1):89-92. PubMed ID: 21533608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of plasma cell dyscrasias with lenalidomide.
    Dimopoulos MA; Kastritis E; Rajkumar SV
    Leukemia; 2008 Jul; 22(7):1343-53. PubMed ID: 18509355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.